Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ani Pharmaceuticals (ANIP) Goodwill: 2013-2024

Historic Goodwill for Ani Pharmaceuticals (ANIP) over the last 12 years, with Dec 2024 value amounting to $60.0 million.

  • Ani Pharmaceuticals' Goodwill rose 3.40% to $62.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $62.5 million, marking a year-over-year increase of 3.40%. This contributed to the annual value of $60.0 million for FY2024, which is 112.57% up from last year.
  • Ani Pharmaceuticals' Goodwill amounted to $60.0 million in FY2024, which was up 112.57% from $28.2 million recorded in FY2023.
  • In the past 5 years, Ani Pharmaceuticals' Goodwill registered a high of $60.0 million during FY2024, and its lowest value of $3.6 million during FY2020.
  • Over the past 3 years, Ani Pharmaceuticals' median Goodwill value was $28.2 million (recorded in 2023), while the average stood at $38.8 million.
  • Data for Ani Pharmaceuticals' Goodwill shows a peak YoY skyrocketed of 675.00% (in 2021) over the last 5 years.
  • Ani Pharmaceuticals' Goodwill (Yearly) stood at $3.6 million in 2020, then spiked by 675.00% to $27.9 million in 2021, then increased by 1.15% to $28.2 million in 2022, then remained steady at $28.2 million in 2023, then soared by 112.57% to $60.0 million in 2024.